DalsnaFinance

Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial

Markets PR Newswire By PR Newswire 28 Jul 2026 13:30 1 min read
Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial

Milestone reflects continued execution of the Company's pivotal U.S. clinical study evaluating EndoZip™ for Endoscopic Sleeve Gastroplasty CAESAREA, Israel, July 28, 2026 /PRNewswire/ -- Nitinotes Ltd., developer of the EndoZip™ Automated Suturing System for Endoscopic Sleeve Gastroplasty...

Milestone reflects continued execution of the Company's pivotal U.S. clinical study evaluating EndoZip™ for Endoscopic Sleeve Gastroplasty CAESAREA, Israel, July 28, 2026 /PRNewswire/ -- Nitinotes Ltd., developer of the EndoZip™ Automated Suturing System for Endoscopic Sleeve Gastroplasty...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.